Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Gabelli cut their FY2020 earnings per share (EPS) estimates for Henry Schein in a note issued to investors on Tuesday. Gabelli analyst K. Kedra now anticipates that the company will earn $4.85 per share for the year, down from their previous estimate of $5.00.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same period in the previous year, the company posted $0.84 EPS. Henry Schein’s quarterly revenue was up 10.3% compared to the same quarter last year.

TRADEMARK VIOLATION WARNING: “FY2020 EPS Estimates for Henry Schein, Inc. (HSIC) Decreased by Gabelli” was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally copied and reposted in violation of US & international copyright and trademark law. The original version of this article can be accessed at https://www.watchlistnews.com/fy2020-eps-estimates-for-henry-schein-inc-hsic-decreased-by-gabelli/1694154.html.

Other equities research analysts also recently issued research reports about the company. Jefferies Group LLC reaffirmed a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research report on Friday, July 21st. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research report on Monday. Royal Bank Of Canada began coverage on Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective on the stock. Finally, Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $89.88.

Shares of Henry Schein (NASDAQ:HSIC) traded down $2.61 during mid-day trading on Thursday, reaching $67.05. The company had a trading volume of 5,070,260 shares, compared to its average volume of 1,106,182. Henry Schein has a 12 month low of $67.02 and a 12 month high of $93.50. The company has a market capitalization of $10,730.00, a P/E ratio of 19.64, a P/E/G ratio of 1.90 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.85 and a current ratio of 1.55.

Large investors have recently made changes to their positions in the company. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares in the last quarter. Sun Life Financial INC raised its position in Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares in the last quarter. FTB Advisors Inc. raised its position in Henry Schein by 100.0% during the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after acquiring an additional 742 shares in the last quarter. Trust Co. of Vermont raised its position in Henry Schein by 56.7% during the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after acquiring an additional 616 shares in the last quarter. Finally, Lee Financial Co raised its position in Henry Schein by 100.0% during the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after acquiring an additional 878 shares in the last quarter. Hedge funds and other institutional investors own 48.16% of the company’s stock.

In other news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.19% of the company’s stock.

Henry Schein declared that its Board of Directors has authorized a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its shares are undervalued.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.